Back to Search

ADEEB JABER, MD

MD

Hospitalist Physician

NPI: 1730231218IndividualAccepts Medicare

Specialties, Licenses & Credentials

Internal Medicine Physician

Internal Medicine

Code: 207R00000X

C175562(CA)
Hospitalist PhysicianPrimary

Hospitalist

Code: 208M00000X

D60390(MD)

CMS Specialties

PrimaryINTERNAL MEDICINE

Education

GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE

Class of 1995

Research & Publications (20)

Determination of ammonium and organic bound nitrogen by inductively coupled plasma emission spectroscopy.
PMID 19362191·Talanta·2009
8-other
Minor contribution of mutations at iniA codon 501 and embC-embA intergenic region in ethambutol-resistant clinical Mycobacterium tuberculosis isolates in Kuwait.
PMID 19146672·Ann Clin Microbiol Antimicrob·2009
8-other
A novel needle for subcutaneous injection of interferon beta-1a: effect on pain in volunteers and satisfaction in patients with multiple sclerosis.
PMID 18845005·BMC Neurol·2008
3-trial
Assessment of the immunogenicity of different interferon beta-1a formulations using ex vivo T-cell assays.
PMID 17118612·J Pharm Biomed Anal·2007
4-observational
Assessment of the safety, tolerability, and PK/PD properties of two new formulations of subcutaneously administered IFN-beta1a: a double-blind, placebo-controlled comparison with the currently available formulation.
PMID 17595888·Int J Clin Pharmacol Ther·2007
4-observational
The influence of timing of administration on the analgesic efficacy of parecoxib in orthopedic surgery.
PMID 17513652·Anesth Analg·2007
4-observational
Effect of the electronic and physicochemical parameters on the carcinogenesis activity of some sulfa drugs using QSAR analysis based on genetic-MLR and genetic-PLS.
PMID 17307223·Chemosphere·2007
8-other
Frequency of embB codon 306 mutations in ethambutol-susceptible and -resistant clinical Mycobacterium tuberculosis isolates in Kuwait.
PMID 17289435·Tuberculosis (Edinb)·2007
8-other
Immunogenicity and tolerability of an investigational formulation of interferon-beta1a: 24- and 48-week interim analyses of a 2-year, single-arm, historically controlled, phase IIIb study in adults with multiple sclerosis.
PMID 17692727·Clin Ther·2007
3-trial
The Rebif new formulation story: it's not trials and error.
PMID 17963425·Drugs R D·2007
6-review

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Request Appointment

Contact & Hours

Address
2001 MEDICAL PKWY
ANNAPOLIS, MD 21401

Locations (2)

Practice Location

2001 MEDICAL PKWY, ANNAPOLIS, MD
(443) 481-1000

Practice Location

15004 Innovation Dr, San Diego, CA
(858) 605-7893

Quick Facts

NPI
1730231218
Entity Type
Individual
Gender
Male
Medicare
Accepted
Specialties
2
Locations
2
Years in Practice
31
Publications
20

Are you this provider?

Claim Your Profile